AI
AI

Tag: BEAM101

Beam Therapeutics Unveils New Findings from BEACON Phase 1/2 Trial of BEAM-101 for Sickle Cell Disease at ASH Annual Meeting

Photo credit: www.investing.com Beam Therapeutics Reports Promising Data from BEACON Trial of BEAM-101 for Sickle Cell Disease SAN DIEGO, Dec. 07,...